Definitive Healthcare Corp.
NASDAQ:DHMedical - Healthcare Information Services
+$0.01 today
- Market cap
- $143.60M
- Beta
- 1.33
- P/E (TTM)
- -0.5
- EPS (TTM)
- -$1.63
Volume 0.43M
Average 0.32M
DH Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
Definitive Healthcare Corp.NASDAQ: DH
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow turns negative
Q1 FY2026 investing cash flow was -$6.22M, compared with $83.55M a year earlier. Trailing-twelve-month investing cash flow was $64.11M.
Context
- Investing cash flow amounted to 63.7% of revenue in FY2025, up 53.2 pp from a year earlier.
- Investing cash flow increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly investing cash flow holds near -$6.22M or moves back toward the trailing-twelve-month quarterly average of $16.03M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 153.88M USD
- Year-over-year change
- +682.7%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 153.88M | +682.7% |
| FY2024 | 2024-12-31 | (26.41M) | +16.9% |
| FY2023 | 2023-12-31 | (31.78M) | +87.2% |
| FY2022 | 2022-12-31 | (248.9M) | -432.6% |
| FY2021 | 2021-12-31 | (46.73M) | — |
Investing Cash Flow vs competitors
How DH compares with its peers on the latest reported figures
- DH's LTM Mar 2026 investing cash flow of $64.11M is the 3rd largest of the 10 companies compared; the peer median is $10.23M.
- Its year-over-year change of -21.0% is the 5th highest of 10, against a peer median of -50.1%.
- Investing cash flow amounts to 26.9% of revenue for DH, versus a peer median of 12.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $643.29M | +114069.8% | +1189.2% | 16411.8% | |
| LTM Mar 2026 | $82.35M | -63.1% | +6.7% | 212.8% | |
| LTM Mar 2026 | $64.11M | -21.0% | — | 26.9% | |
| LTM Mar 2026 | $15.76M | -51.4% | — | — | |
| LTM Mar 2026 | $15.21M | +4.9% | -38.3% | 4.4% | |
| LTM Mar 2026 | $10.93M | +33.1% | — | 13.5% | |
| LTM Feb 2026 | $10.23M | -68.1% | -6.1% | 12.7% | |
| LTM Mar 2026 | $9.55M | -50.1% | +2.9% | 6.9% | |
| LTM Mar 2026 | $2.91M | -5.5% | — | 2.1% | |
| LTM Mar 2026 | $1.48M | -96.9% | +22.7% | — | |
| Peer median (excluding DH) | $10.23M | -50.1% | +4.8% | 12.7% | |
Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (62.32M) | (22.26M) | (202.39M) | (591.45M) | (199.3M) |
| Depreciation & Amortization | 59.95M | 56.9M | 51.75M | 51.67M | 56.11M |
| Deferred Income Tax | (587K) | (26.67M) | (18.71M) | (119.58M) | (10.88M) |
| Stock-Based Compensation | 9.96M | 36.43M | 48.74M | 38.09M | 29.14M |
| Change in Working Capital | (2.51M) | (21.95M) | (30.39M) | (25.93M) | (9.42M) |
| Accounts Receivables | (10.73M) | (13.22M) | 811K | 5.69M | 1.38M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 3.42M | 358K | 1.33M | (5.46M) | (1.09M) |
| Other Working Capital | 4.79M | (9.09M) | (32.53M) | (26.17M) | (9.71M) |
| Other Non-Cash Items | 20.73M | 13.12M | 192.19M | 705.4M | 188.12M |
| Operating Cash Flow | 25.21M | 35.58M | 41.19M | 58.2M | 53.78M |
| Capital Expenditures | (6.73M) | (8.33M) | (2.98M) | (12.34M) | (16.72M) |
| Acquisitions (Net) | (40M) | (56.3M) | (45.02M) | (13.53M) | 0 |
| Purchases of Investments | 0 | (337.96M) | (259.21M) | (304.3M) | (64.07M) |
| Sales of Investments | 0 | 153.68M | 275.43M | 303.77M | 234.66M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (46.73M) | (248.9M) | (31.78M) | (26.41M) | 153.88M |
| Debt Repayment | (199.46M) | (6.88M) | (8.59M) | (13.75M) | (79.47M) |
| Common Stock Issued | 834.95M | (1.73M) | (30K) | 0 | 0 |
| Common Stock Repurchased | (231.77M) | 0 | 0 | (22.37M) | (49.45M) |
| Dividends Paid | (8.13M) | (12.87M) | (12.28M) | (5.14M) | (3.15M) |
| Other Financing Activities | (11.22M) | (5.22M) | (4.68M) | (15.5M) | (18.72M) |
| Financing Cash Flow | 384.37M | (26.7M) | (25.58M) | (56.75M) | (150.79M) |
| Effect of Forex Changes | (129K) | (544K) | 218K | (636K) | 1.39M |
| Net Change in Cash | 362.72M | (240.56M) | (15.96M) | (25.6M) | 58.25M |
| Free Cash Flow | 18.48M | 27.25M | 38.21M | 45.85M | 37.06M |
Definitive Healthcare Corp.
NASDAQ:DH
Intrinsic Alpha fair value
Locked
Current Price
$1.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.